Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Synthesis of the IGF-II-like hormone vesiculin using regioselective formation of disulfide bonds.

Williams GM, Cooper GJ, Lee K, Whiting L, Brimble MA.

Org Biomol Chem. 2013 May 21;11(19):3145-50. doi: 10.1039/c3ob40322j. Epub 2013 Mar 28.

PMID:
23538787
2.

Using mass spectrometry to detect, differentiate, and semiquantitate closely related peptide hormones in complex milieu: measurement of IGF-II and vesiculin.

Lee KL, Middleditch MJ, Williams GM, Brimble MA, Cooper GJ.

Endocrinology. 2015 Mar;156(3):1194-9. doi: 10.1210/en.2014-1593. Epub 2014 Dec 29.

PMID:
25545381
3.

The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor.

Sakano K, Enjoh T, Numata F, Fujiwara H, Marumoto Y, Higashihashi N, Sato Y, Perdue JF, Fujita-Yamaguchi Y.

J Biol Chem. 1991 Nov 5;266(31):20626-35.

4.

IGF-II is up-regulated and myofibres are hypertrophied in regenerating soleus of mice lacking FGF6.

Armand AS, Lécolle S, Launay T, Pariset C, Fiore F, Della Gaspera B, Birnbaum D, Chanoine C, Charbonnier F.

Exp Cell Res. 2004 Jul 1;297(1):27-38.

PMID:
15194422
5.

A novel two-chain IGF-II-derived peptide from purified β-cell granules.

Buchanan CM, Phillips AR, Cooper GJ.

Growth Horm IGF Res. 2010 Oct;20(5):360-6. doi: 10.1016/j.ghir.2010.06.003. Epub 2010 Jul 24.

PMID:
20656537
6.

The receptor for insulin-like growth factor II mediates an insulin-like response.

Hari J, Pierce SB, Morgan DO, Sara V, Smith MC, Roth RA.

EMBO J. 1987 Nov;6(11):3367-71.

7.
8.

Growth hormone stimulates protein synthesis in bovine skeletal muscle cells without altering insulin-like growth factor-I mRNA expression.

Ge X, Yu J, Jiang H.

J Anim Sci. 2012 Apr;90(4):1126-33. doi: 10.2527/jas.2011-4358. Epub 2011 Nov 18.

9.
11.

Ultrastructural localization of insulin-like growth factor-2 (IGF-2) to the secretory granules of insulin cells: a study in normal and diabetic (GK) rats.

Höög A, Hu W, Abdel-Halim SM, Falkmer S, Qing L, Grimelius L.

Ultrastruct Pathol. 1997 Sep-Oct;21(5):457-66.

PMID:
9273977
12.

Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF-II.

Alvino CL, Ong SC, McNeil KA, Delaine C, Booker GW, Wallace JC, Forbes BE.

PLoS One. 2011;6(11):e27488. doi: 10.1371/journal.pone.0027488. Epub 2011 Nov 28.

13.

Structure and activity dependence of recombinant human insulin-like growth factor II on disulfide bond pairing.

Smith MC, Cook JA, Furman TC, Occolowitz JL.

J Biol Chem. 1989 Jun 5;264(16):9314-21.

14.

The insulin-like growth factor system and cancer.

LeRoith D, Roberts CT Jr.

Cancer Lett. 2003 Jun 10;195(2):127-37. Review.

PMID:
12767520
15.

Role of native disulfide bonds in the structure and activity of insulin-like growth factor 1: genetic models of protein-folding intermediates.

Narhi LO, Hua QX, Arakawa T, Fox GM, Tsai L, Rosenfeld R, Holst P, Miller JA, Weiss MA.

Biochemistry. 1993 May 18;32(19):5214-21.

PMID:
8494898
16.

A novel PKB/Akt inhibitor, MK-2206, effectively inhibits insulin-stimulated glucose metabolism and protein synthesis in isolated rat skeletal muscle.

Lai YC, Liu Y, Jacobs R, Rider MH.

Biochem J. 2012 Oct 1;447(1):137-47. doi: 10.1042/BJ20120772.

PMID:
22793019
17.

Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.

Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A, Vigneri R.

Mol Cell Biol. 1999 May;19(5):3278-88.

18.

Insulin-like growth factors and pancreas beta cells.

van Haeften TW, Twickler TB.

Eur J Clin Invest. 2004 Apr;34(4):249-55.

PMID:
15086355
20.

Contribution of residues A54 and L55 of the human insulin-like growth factor-II (IGF-II) A domain to Type 2 IGF receptor binding specificity.

Forbe BE, McNeil KA, Scott CD, Surinya KH, Cosgrove LJ, Wallace JC.

Growth Factors. 2001;19(3):163-73.

PMID:
11811790

Supplemental Content

Support Center